SCHEMBL862034

SCHEMBL862034

OC=CCC1(CC=CO)COC1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5439874 0.90
SCHEMBL860534 0.89
SCHEMBL45545 0.81
SCHEMBL10773155 0.70
SCHEMBL7943787 0.68 USP2 (0.32)
SCHEMBL6277554 0.67 EPHX1 (0.39) EPHX1
SCHEMBL2106334 0.67 PDE9A (0.32) EPHX1
SCHEMBL6046326 0.62
SCHEMBL521656 0.61
SCHEMBL1533016 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954346-B2 Resin and ink INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2021-03-23 US claimed
US-20200207923-A1 RESIN AND INK INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2020-07-02 US claimed
EP-1355975-B1 PROCESS FOR MANUFACTURE OF A DENDRITIC POLYETHER PERSTORP SPECIALTY CHEM AB (SE) 2016-08-31 EP claimed
US-8883942-B2 Terminally unsaturated, oxetane-based macromonomers, and methods for the production thereof BYK-CHEMIE GMBH (DE) 2014-11-11 US claimed
EP-2432820-B1 TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHOD FOR THE PRODUCTION THEREOF BYK CHEMIE GMBH (DE) 2012-10-24 EP claimed
EP-1468040-B1 CHAIN EXTENDED DENDRITIC POLYETHER PERSTORP SPECIALTY CHEM AB (SE) 2012-06-13 EP claimed
US-20120142888-A1 TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHODS FOR THE PRODUCTION THEREOF BYK-CHEMIE GMBH (DE) 2012-06-07 US claimed
EP-2432820-A2 TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHOD FOR THE PRODUCTION THEREOF BYK-Chemie GmbH (DE) 2012-03-28 EP claimed
EP-2035487-B1 POLYHYDROXYFUNCTIONAL POLYSILOXANES, METHOD FOR THE PRODUCTION AND USE THEREOF BYK CHEMIE GMBH (DE) 2011-05-11 EP claimed
WO-2010133289-A2 TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHOD FOR THE PRODUCTION THEREOF BYK-CHEMIE GMBH (DE) 2010-11-25 WO claimed
US-7091308-B2 Chain extended dendritic polyether PERSTORP SPECIALTY CHEMICALS AB (SE) 2006-08-15 US claimed
US-20050131205-A1 For use in preparation of air drying allyd resins, 1-and 2-component polyurethane coatings and adhesives, saturated and unsaturated polyesters, toughening agents for thermosetting resins, such as epoxy resins, unsaturated polyester, vinyl esters, polyurethanes, maleimides PERSTORP SPECIALTY CHEMICALS AB (SE) 2005-06-16 US claimed
EP-1468040-A1 CHAIN EXTENDED DENDRITIC POLYETHER Perstorp Specialty Chemicals AB (SE) 2004-10-20 EP claimed
US-20040059086-A1 Process for manufacture of a dendritic polyether PERSTORP SPECIALTY CHEMICALS AB (SE) 2004-03-25 US claimed
EP-1355975-A1 PROCESS FOR MANUFACTURE OF A DENDRITIC POLYETHER Perstorp Specialty Chemicals AB (SE) 2003-10-29 EP claimed
WO-2003062306-A1 CHAIN EXTENDED DENDRITIC POLYETHER PERSTORP SPECIALTY CHEMICALS AB (SE) 2003-07-31 WO claimed
WO-2003062297-A1 POLYURETHANE FOAM COMPOSITION COMPRISING CHAIN EXTENDED DENDRITIC POLYETHER PERSTORP SPECIALTY CHEMICALS AB (SE) 2003-07-31 WO claimed
WO-2003046048-A1 PROCESS FOR ALKYLATION OF AN ALKOXYLATED MONO DI, TRI OR POLYHYDRIC COMPOUND PERSTORP SPECIALTY CHEMICALS AB (SE) 2003-06-05 WO claimed
WO-2002040572-A1 PROCESS FOR MANUFACTURE OF A DENDRITIC POLYETHER PERSTORP SPECIALTY CHEMICALS AB (SE) 2002-05-23 WO claimed
WO-2002036660-A1 NOVEL BRANCHED OXETANE POLYESTER PERSTORP SPECIALTY CHEMICALS AB (SE) 2002-05-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142888-A1 TERMINALLY UNSATURATED, OXETANE-BASED MACROMONOMERS, AND METHODS FOR THE PRODUCTION THEREOF OXER1, ALOX12, ALOX15 EPHX1 228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.